Medical Policy

The AIIMS-Delhi is planning to start a weekly OPD to spread awareness among patients on how they would like to be medically treated or not treated should they lose the decision-making capacity due to an accident or disease. The proposed move comes in the backdrop of the Union health ministry issuing draft "Guidelines for Withdrawal of Life Support in Terminally Ill Patients". Dr Sushma Bhatnagar, the chief of Dr B R Ambedkar Institute Rotary Cancer Hospital at AIIMS, said that the weekly OPD would be started by the cancer institute to extend counseling to registered patients about the Advance Medical Directives (AMD) and get the legal document made. Advance Medical Directives (AMD) is a written declaration made by a person with decision-making capacity documenting how they would like to be medically treated or not treated should they lose capacity. "Terminally ill patients or those who suffer fatal accidents and are not salvageable are put on life support and keep on getting treate

The University of East Anglia (UEA) has declares a dedicated scholarship of £4,000 annually for Indian students for whole programme in biomedical science within the UK's NHS

Applicants can get their Foreign Medical Graduate Exam (FMGE) 2023 admit cards via official site at nbe.edu.in, utilising their login credentials. It will be released by NBEMS

According to the latest data from the National Crime Records Bureau (NCRB), deaths due to cardiac arrests saw a 12.5 per cent rise, from 28,413 in 2021 to 32,457 in 2022

India is currently the third-largest pharmaceutical industry in the world by volume, with a market size of around $50 billion, according to the Ministry of Chemicals and Fertilisers

Drug firm Lupin on Friday said it has tied up with Unitaid, The Aurum Institute, the Clinton Health Access Initiative (CHAI), and other global procurement agencies to support tuberculosis prevention treatment initiative to be rolled out to 138 countries. As per the agreement, the Mumbai-based firm will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price in various regions, including many low-and middle-income countries with a large burden of tuberculosis (TB). "We are committed to enhancing the global access to affordable and high-quality drugs and APIs for the treatment of tuberculosis... "Through this, we will further reinforce our long legacy to provide shorter, more patient-friendly treatment options to prevent TB," Lupin Managing Director Nilesh Gupta said in a statement. Lupin is a leading player in the cardiovascular, anti-diabetic, and respiratory segments.

Israel and Argentina will jointly sponsor five research projects in the fields of medicine and green energy, Israel's Ministry of Innovation, Science and Technology said in a statement

The delivery giant also offers Rs 5,000 worth of Out-Patient Department (OPD) support, which can be extended to their families

This indicates a sharp increase in awareness and demand for high cover protection policies

An announcement on the matter is expected over the weekend

The country has one government doctor for 11,000 people. The WHO recommends one doctor for 1,000 people. The situation is worse in rural India where a government doctor serves over 30,000 people

It is, therefore, necessary to carefully read the policy and understand the scope of coverage and benefits available

Moving to a new company means losing out on continuity benefits